MacroGenics Earns $60 Million Milestone with U.S. FDA Approval of Teplizumab

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/1/2026

1. SPY
2. MDT
3. ENOV
4. AON
5. AZN
6. BLSM
7. KRMN
8. GRMN
9. GPRO
10. VRSK

Go back to MacroGenics Earns $60 Million Milestone with U.S. FDA Approval of Teplizumab
MACROGENICS (NASDAQ: MGNX) Delayed: 3.96 -0.03 (0.75%)
Previous Close $3.99    52 Week High $36.11 
Open $3.98    52 Week Low $14.84 
Day High $4.02    P/E 10.15 
Day Low $3.89    EPS $0.39 
Volume 105,149